Loading...
AxoGen, Inc.
AXGN•NASDAQ
Healthcare
Medical - Devices
$13.37
$0.16(1.21%)
AxoGen, Inc. (AXGN) Financial Performance & Income Statement Overview
Review AxoGen, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
17.81%
↑ 17.81%
Operating Income Growth
84.68%
↑ 84.68%
Net Income Growth
54.12%
↑ 54.12%
Operating Cash Flow Growth
179.34%
↑ 179.34%
Operating Margin
-0.25%
↓ 0.25%
Gross Margin
74.18%
↑ 74.18%
Net Profit Margin
-3.68%
↓ 3.68%
ROE
-7.09%
↓ 7.09%
ROIC
-0.27%
↓ 0.27%
AxoGen, Inc. (AXGN) Income Statement & Financial Overview
Review AxoGen, Inc.'s (AXGN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $49.41M | $48.64M | $47.91M | $41.38M |
| Cost of Revenue | $11.83M | $12.21M | $12.57M | $8.76M |
| Gross Profit | $37.58M | $36.44M | $35.34M | $32.62M |
| Gross Profit Ratio | $0.76 | $0.75 | $0.74 | $0.79 |
| R&D Expenses | $6.73M | $7.00M | $6.66M | $7.41M |
| SG&A Expenses | $28.92M | $29.76M | $29.11M | $29.77M |
| Operating Expenses | $35.65M | $36.75M | $35.77M | $37.18M |
| Total Costs & Expenses | $47.48M | $48.96M | $48.34M | $45.94M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.80M | $1.89M | $2.19M | $2.33M |
| Depreciation & Amortization | $1.92M | $1.97M | $2.06M | $1.90M |
| EBITDA | $4.17M | $2.00M | $1.63M | -$2.41M |
| EBITDA Ratio | $0.08 | $0.04 | $0.03 | -$0.06 |
| Operating Income | $1.93M | -$316000.00 | -$428000.00 | -$4.56M |
| Operating Income Ratio | $0.04 | -$0.006 | -$0.009 | -$0.11 |
| Other Income/Expenses (Net) | -$1.48M | -$1.54M | -$1.49M | -$2.08M |
| Income Before Tax | $450000.00 | -$1.86M | -$1.92M | -$6.63M |
| Income Before Tax Ratio | $0.009 | -$0.04 | -$0.04 | -$0.16 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.85M |
| Net Income | $450000.00 | -$1.86M | -$1.92M | -$6.63M |
| Net Income Ratio | $0.009 | -$0.04 | -$0.04 | -$0.16 |
| EPS | $0.01 | -$0.04 | -$0.04 | -$0.15 |
| Diluted EPS | $0.009 | -$0.04 | -$0.04 | -$0.15 |
| Weighted Avg Shares Outstanding | $44.88M | $43.88M | $43.71M | $43.23M |
| Weighted Avg Shares Outstanding (Diluted) | $48.06M | $43.88M | $43.71M | $43.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan